Abstract
Aims
A sliding-scale (SS) regimen is discouraged to correct hyperglycemia in hospital patients, but there is resistance to adoption of basal–bolus (BB) treatment in surgical units. We tested the feasibility and the effects of a nurse-based BB regimen in orthopedic surgery.
Methods
Following an intense training to implement a protocol amenable by nurses, a group of patients admitted with hyperglycemia in an orthopedic institute were prospectively followed according to a basal–bolus insulin regimen (BB, n = 80). They were compared with a hyperglycemic group eventually treated by sliding-scale insulin on demand (SS, n = 122). Diabetes was present in 196 cases. Metabolic control was assessed during the first 3 days of surgery; outcome data were tested by logistic regression, after adjusting for propensity score.
Result
Average blood glucose and glucose variability were lower in BB versus SS (P < 0.001), in the presence of similar 3-day insulin doses. Complications were recorded in 68 cases (16.2% vs. 45.1% in BB and SS, respectively). BB regimen was associated with propensity-adjusted reduction in all adverse events [odds ratio (OR) 0.36; 95% confidence interval (CI) 0.17–0.76] and of systemic infections (OR 0.18; 95% CI 0.07–0.50) and with shorter hospital stay (8.8 ± SD 5.2 days vs. 12.5 ± 7.4; P < 0.01). The superiority of BB regimen was confirmed in the pair-matched analysis.
Conclusions
The study proves the feasibility and the superiority of nurse-based BB versus SS treatment in metabolic control and on the risk of adverse events in orthopedic surgery patients with hyperglycemia.
Similar content being viewed by others
References
Pieralli F, Bazzini C, Fabbri A et al (2016) The classification of hospitalized patients with hyperglycemia and its implication on outcome: results from a prospective observational study in internal medicine. Intern Emerg Med 11:649–656
Pagano E, De Rosa M, Rossi E et al (2016) The relative burden of diabetes complications on healthcare costs: the population-based CINECA-SID ARNO Diabetes Observatory. Nutr Metab Cardiovasc Dis 26:944–950
Dungan KM, Braithwaite SS, Preiser JC (2009) Stress hyperglycaemia. Lancet 373:1798–1807
Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE (2002) Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 87:978–982
Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC (2001) Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 32:2426–2432
Paciaroni M, Agnelli G, Caso V et al (2009) Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke. Cerebrovasc Dis 28:119–123
Martin ET, Kaye KS, Knott C et al (2016) Diabetes and risk of surgical site infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 37:88–99
Yang Y, Kim TH, Yoon KH et al (2017) The stress hyperglycemia ratio, an index of relative hyperglycemia, as a predictor of clinical outcomes after percutaneous coronary intervention. Int J Cardiol 241:57–63
Dhatariya K, Levy N, Kilvert A et al (2012) NHS Diabetes guideline for the perioperative management of the adult patient with diabetes. Diabet Med 29:420–433
Associazione Medici Diabetologi (AMD), Società Italiana di Diabetologia (SID). Standard Italiani per la Cura del Diabete. In: AMD, SID, 2018
Akiboye F, Rayman G (2017) Management of hyperglycemia and diabetes in orthopedic surgery. Curr Diab Rep 17:13
Kerby JD, Griffin RL, MacLennan P, Rue LW 3rd (2012) Stress-induced hyperglycemia, not diabetic hyperglycemia, is associated with higher mortality in trauma. Ann Surg 256:446–452
American Diabetes Association (2019) 15. Diabetes care in the hospital: standards of medical care in diabetes-2019. Diabetes Care 42:S173–S181
Gallagher JM, Erich RA, Gattermeyer R, Beam KK (2017) Postoperative hyperglycemia can be safely and effectively controlled in both diabetic and nondiabetic patients with use of a subcutaneous insulin protocol. JB JS Open Access 2:e0008
Sternthal E, Underwood P, Mantzoros CS (2015) Slip sliding away: the need for continued discussion of the use of insulin sliding scale in hospitalized patients. Metabolism 64:935–936
Lee YY, Lin YM, Leu WJ et al (2015) Sliding-scale insulin used for blood glucose control: a meta-analysis of randomized controlled trials. Metabolism 64:1183–1192
Umpierrez GE, Smiley D, Jacobs S et al (2011) Randomized study of basal–bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care 34:256–261
Malmberg K (1997) Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ 314:1512–1515
American Diabetes Association (2020) 15. Diabetes care in the hospital: standards of medical care in diabetes-2020. Diabetes Care 43:S193–S202
Roberts GW, Quinn SJ, Valentine N et al (2015) Relative hyperglycemia, a marker of critical illness: introducing the stress hyperglycemia ratio. J Clin Endocrinol Metab 100:4490–4497
Miller DB (2011) Why won’t the sliding scale go away? Can J Diabetes 35:340–343
Golightly LK, Jones MA, Hamamura DH, Stolpman NM, McDermott MT (2006) Management of diabetes mellitus in hospitalized patients: efficiency and effectiveness of sliding-scale insulin therapy. Pharmacotherapy 26:1421–1432
Umpierrez GE, Smiley D, Zisman A et al (2007) Randomized study of basal–bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care 30:2181–2186
Canadian Agency for Drugs and Technologies in Health (2017) Basal–bolus versus sliding-scale insulin therapy in the acute care hospital setting: a review of comparative clinical effectiveness and cost-effectiveness. Canadian Agency for Drugs and Technologies in Health, Ottawa
Rubin DB (2007) The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials. Stat Med 26:20–36
Chrastil J, Anderson MB, Stevens V, Anand R, Peters CL, Pelt CE (2015) Is hemoglobin A1c or perioperative hyperglycemia predictive of periprosthetic joint infection or death following primary total joint arthroplasty? J Arthroplast 30:1197–1202
Karunakar MA, Staples KS (2010) Does stress-induced hyperglycemia increase the risk of perioperative infectious complications in orthopaedic trauma patients? J Orthop Trauma 24:752–756
Krinsley JS (2003) Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 78:1471–1478
Richards JE, Kauffmann RM, Obremskey WT, May AK (2013) Stress-induced hyperglycemia as a risk factor for surgical-site infection in nondiabetic orthopedic trauma patients admitted to the intensive care unit. J Orthop Trauma 27:16–21
Richards JE, Kauffmann RM, Zuckerman SL, Obremskey WT, May AK (2012) Relationship of hyperglycemia and surgical-site infection in orthopaedic surgery. J Bone Joint Surg Am 94:1181–1186
Di Luzio R, Dusi R, Mazzotti A, Petroni ML, Marchesini G, Bianchi G (2020) Stress hyperglycemia and complications following traumatic injuries in individuals with/without diabetes: the case of orthopedic surgery. Diabetes Metab Syndr Obes 13:9–17
Foster EM (2003) Propensity score matching: an illustrative analysis of dose response. Med Care 41:1183–1192
Rosenbaum PR, Rubin DB (1983) The central role of the propensity score in observational studies for causal effects. Biometrika 70:41–55
Umpierrez GE, Palacio A, Smiley D (2007) Sliding scale insulin use: myth or insanity? Am J Med 120:563–567
Funding
RDL was supported by grant of Fondazione Diabete Ricerca, Società Italiana di Diabetologia (SID) 2014, Rome, Italy.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest in relation to the material included in the manuscript.
Ethical standard statement
The study was approved by the independent ethical committee of Sant’Orsola-Malpihi university hospital, Protocol n. 65/2015/O/0SS, Amendment n. 46/2016/O.
Informed consent
Informed consent was obtained from all patients included in the study.
Additional information
Managed by Antonio Secchi.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Di Luzio, R., Dusi, R., Morigi, A. et al. Nurse-managed basal-bolus versus sliding-scale insulin regimen in subjects with hyperglycemia at admission for orthopedic surgery: a propensity score approach. Acta Diabetol 57, 835–842 (2020). https://doi.org/10.1007/s00592-020-01503-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-020-01503-x